Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Leen, Ann M
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Leung WK
,
Chavez AGTorres
,
French-Kim M
,
Shafer P
,
Mamonkin M
,
Hill LQC
,
Kuvalekar M
,
Velazquez Y
,
Watanabe A
,
Watanabe N
, et al.
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
Blood. 2024.
PubMed
Google Scholar
M
Leen AM
,
Bollard CM
,
Mendizabal AM
,
Shpall EJ
,
Szabolcs P
,
Antin JH
,
Kapoor N
,
Pai S-Y
,
Rowley SD
,
Kebriaei P
, et al.
Multicenter study of banked third party virus-specific T-cells to treat severe viral infections after hematopoietic stem cell transplantation.
Blood. 2013.
PubMed
Google Scholar
L
Zhou X
,
Di Stasi A
,
Tey S-K
,
Krance RA
,
Martinez C
,
Leung KS
,
Durett AG
,
Wu M-F
,
Liu H
,
Leen AM
, et al.
Long-term outcome and immune reconstitution after haploidentical stem cell transplant in recipients of allodepleted-T-cells expressing the inducible caspase-9 safety transgene.
Blood. 2014.
PubMed
Google Scholar
K
Anurathapan U
,
Chan RC
,
Hindi HF
,
Mucharla R
,
Bajgain P
,
Hayes BC
,
Fisher WE
,
Heslop HE
,
Rooney CM
,
Brenner MK
, et al.
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.
Mol Ther. 2013.
PubMed
Google Scholar
E
Leung WK
,
Workineh A
,
Mukhi S
,
Tzannou I
,
Brenner D
,
Watanabe N
,
Leen AM
,
Lulla P
.
Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemia.
Blood Adv. 2020;4(2):387-397.
PubMed
Google Scholar
Sun J
,
Huye LE
,
Lapteva N
,
Mamonkin M
,
Hiregange M
,
Ballard B
,
Dakhova O
,
Raghavan D
,
Durett AG
,
Perna SK
, et al.
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.
J Immunother Cancer. 2015;3:5.
PubMed
Google Scholar